Coreline Soft Expands Emergency AI Portfolio Beyond Brain Hemorrhage to Pulmonary Embolism, Aortic Disease and Fractures

South Korean AI medical firm Coreline Soft is broadening its emergency imaging arsenal beyond brain hemorrhage to incorporate pulmonary embolism, aortic diseases, and bone fractures. This expansion aims to bolster its standing in urgent care. The firm unveiled four AI-powered imaging solutions at the 2026 Korean Society of Emergency Medicine Fall Conference, held on October 15–16 in Seoul.

These include AVIEW NeuroCAD for detecting brain hemorrhages, AVIEW Aorta for identifying aortic issues, AVIEW PE for pulmonary embolism, and the recently introduced AVIEW BoneFX for fracture diagnosis using X-ray images. The company's growth in emergency AI solutions is part of a larger trend toward aiding clinicians in prioritizing critical imaging findings to improve workflows and patient care.

The urgency of emergencies such as intracranial hemorrhage, aortic dissection, and pulmonary embolism is underscored by statistics showing high in-hospital mortality rates of 14.5% and 14.4% respectively. To tackle this, AI imaging tools are being developed to help clinicians swiftly recognize potentially critical conditions and prioritize urgent cases.

Coreline Soft's NeuroCAD, the first AI solution for intracranial hemorrhage, has seen its annual usage surge from roughly 30,000 to 50,000 cases, even in a non-reimbursed setting. This success has paved the way for the introduction of AVIEW Aorta, AVIEW PE, and AVIEW BoneFX, each receiving South Korea's Innovative Medical Device designation.

While NeuroCAD focuses on neurological emergencies, BoneFX brings X-ray analysis of traumatic injuries into the mix. Coreline Soft's ultimate goal is to create a comprehensive emergency imaging AI portfolio that helps physicians spot significant abnormalities across various disease categories, rather than just replacing medical professionals.